Literature DB >> 17061153

Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma.

R Russo1, H Medbury, A Guiffre, H Englert, N Manolios.   

Abstract

The aetiology and pathogenesis of scleroderma is incompletely understood. Recently, a cell called the fibrocyte has been shown to be derived from circulating monocytes with the ability to produce collagen. The aim of this study was to evaluate differences in the cell surface characteristics of circulating fibrocyte progenitors (monocytes) in patients with limited scleroderma compared to controls. A case-control study was performed in eight patients with limited scleroderma, which were matched with eight controls. Three-colour flow cytometry was used to assess the relative expression of cell surface markers. Statistical analysis then compared the relative expression between the two groups. In this preliminary study, there were no significant differences in the expression of circulating monocyte surface molecules involved with cell transformation, function, or migration presumed to give rise to fibrocytes, in a population of patients with limited scleroderma. Various explanations for the results are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061153     DOI: 10.1007/s10067-006-0461-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  9 in total

1.  Peripheral blood fibrocytes: differentiation pathway and migration to wound sites.

Authors:  R Abe; S C Donnelly; T Peng; R Bucala; C N Metz
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

2.  Inhibition of fibrocyte differentiation by serum amyloid P.

Authors:  Darrell Pilling; Christopher D Buckley; Mike Salmon; Richard H Gomer
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

3.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

4.  Nephrogenic fibrosing dermopathy.

Authors:  S E Cowper; L D Su; J Bhawan; H S Robin; P E LeBoit
Journal:  Am J Dermatopathol       Date:  2001-10       Impact factor: 1.533

5.  CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma.

Authors:  S Aiba; N Tabata; H Ohtani; H Tagami
Journal:  Arch Dermatol       Date:  1994-05

6.  Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair.

Authors:  R Bucala; L A Spiegel; J Chesney; M Hogan; A Cerami
Journal:  Mol Med       Date:  1994-11       Impact factor: 6.354

7.  Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast.

Authors:  E C LeRoy
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis.

Authors:  Conrad Hauser; Gürkan Kaya; Carlo Chizzolini
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

  9 in total
  6 in total

Review 1.  Fibrocytes in health and disease.

Authors:  Erica L Herzog; Richard Bucala
Journal:  Exp Hematol       Date:  2010-03-18       Impact factor: 3.084

2.  Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study.

Authors:  Barbara Ruaro; Stefano Soldano; Vanessa Smith; Sabrina Paolino; Paola Contini; Paola Montagna; Carmen Pizzorni; Andrea Casabella; Samuele Tardito; Alberto Sulli; Maurizio Cutolo
Journal:  Rheumatol Int       Date:  2019-05-06       Impact factor: 2.631

Review 3.  Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Int J Biochem Cell Biol       Date:  2009-10-20       Impact factor: 5.085

Review 4.  Circulating progenitor cells and scleroderma.

Authors:  Richard H Gomer
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

5.  The vascular microenvironment and systemic sclerosis.

Authors:  Tracy Frech; Nathan Hatton; Boaz Markewitz; Mary Beth Scholand; Richard Cawthon; Amit Patel; Allen Sawitzke
Journal:  Int J Rheumatol       Date:  2010-08-10

6.  Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.

Authors:  Maurizio Cutolo; Stefano Soldano; Paola Montagna; Amelia Chiara Trombetta; Paola Contini; Barbara Ruaro; Alberto Sulli; Stefano Scabini; Emanuela Stratta; Sabrina Paolino; Carmen Pizzorni; Vanessa Smith; Renata Brizzolara
Journal:  Arthritis Res Ther       Date:  2018-07-27       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.